UBS Group’s Itamar Medical Ltd. American Depository Shares ITMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-5,939
Closed -$180K 11269
2021
Q3
$180K Buy
5,939
+1,126
+23% +$24.9K ﹤0.01% 5398
2021
Q2
$113K Buy
4,813
+1,602
+50% +$35.8K ﹤0.01% 5787
2021
Q1
$77K Buy
3,211
+716
+29% +$17K ﹤0.01% 6169
2020
Q4
$50K Buy
2,495
+1,499
+151% +$29.9K ﹤0.01% 6193
2020
Q3
$20K Buy
+996
New +$22.4K ﹤0.01% 6326
2020
Q2
Sell
-16
Closed 8564
2020
Q1
$0 Buy
+16
New +$218 ﹤0.01% 8632
2019
Q2
Sell
-500
Closed -$5K 8321
2019
Q1
$5K Buy
+500
New +$6.18K ﹤0.01% 7210

Other funds holding ITMR

UBS Group's ITMR Position: Q4 2021 in Review

UBS Group sold out of Itamar Medical Ltd. American Depository Shares (ITMR) in Q4 2021, closing a stake of 5,939 shares — an estimated $180K sold.

UBS Group first reported a position in ITMR in Q1 2019 and held it in 7 quarters. The position peaked at $180K in Q3 2021. 3 funds tracked by Wall St. Rank hold ITMR as of Q4 2021.

  • UBS Group reported no remaining Itamar Medical Ltd. American Depository Shares position as of Q4 2021 after selling out during the quarter.
  • UBS Group sold 5,939 Itamar Medical Ltd. American Depository Shares shares in Q4 2021, an estimated $180K.
  • UBS Group first reported a position in Itamar Medical Ltd. American Depository Shares in Q1 2019 and held it in 7 quarters.
  • UBS Group's Itamar Medical Ltd. American Depository Shares position peaked at $180K in Q3 2021.
  • 3 funds tracked by Wall St. Rank held Itamar Medical Ltd. American Depository Shares as of Q4 2021.

Based on UBS Group's 13F filing for Q4 2021, filed 14 Feb 2022.